Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis

Clinical Gastroenterology and Hepatology

Volumn 16, Issue 2, 2018, Pages 198-210.e2

  Rich, Nicole E ^a   Oji, Stefany ^a   Mufti, Arjmand R ^a   Browning, Jeffrey D ^a   Parikh, Neehar D ^b   Odewole, Mobolaji ^a   Mayo, Helen ^c   Singal, Amit G ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Disparities; Ethnicity; Fatty Liver Disease; Nonalcoholic Steatohepatitis

Indexed keywords

ARTICLE; BLACK PERSON; CAUCASIAN; DISEASE BURDEN; DISEASE SEVERITY; ETHNIC DIFFERENCE; HIGH RISK POPULATION; HISPANIC; HUMAN; META ANALYSIS; MORTALITY RATE; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREVALENCE; PROGNOSIS; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; UNITED STATES; COMPLICATION; FATTY LIVER; LIVER CIRRHOSIS; MORTALITY; PATHOLOGY; SURVIVAL ANALYSIS;

FATTY LIVER; HUMANS; LIVER CIRRHOSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; PREVALENCE; RACE FACTORS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 85044758053     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2017.09.041     Document Type: Article

References (49)

1. Rinella, M.E., Nonalcoholic fatty liver disease: a systematic review. JAMA 313 (2015), 2263–2273.
2. Ogden, C.L., Carroll, M.D., Kit, B.K., et al. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311 (2014), 806–814.
3. Vernon, G., Baranova, A., Younossi, Z.M., Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34 (2011), 274–285.
4. Browning, J.D., Kumar, K.S., Saboorian, M.H., et al. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroenterol 99 (2004), 292–298.
5. Caldwell, S.H., Harris, D.M., Patrie, J.T., et al. Is NASH underdiagnosed among African Americans?. Am J Gastroenterol 97 (2002), 1496–1500.
6. Wei, J.L., Leung, J.C.-F., Loong, T.C.-W., et al. Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance spectroscopy. Am J Gastroenterol 110 (2015), 1306–1315.
7. Moher, D., Liberati, A., Tetzlaff, J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62 (2009), 1006–1012.
8. Wu, S., Wu, F., Ding, Y., et al. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis. Sci Rep, 6, 2016, 33386.
9. Birerdinc, A., Stepanova, M., Pawloski, L., et al. Caffeine is protective in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 35 (2012), 76–82.
10. Younossi, Z.M., Stepanova, M., Negro, F., et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine 91 (2012), 319–327.
11. Wagenknecht, L.E., Palmer, N.D., Bowden, D.W., et al. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study. Liver Int 31 (2011), 412–416.
12. Loomba, R., Schork, N., Chen, C.H., et al. Heritability of hepatic fibrosis and steatosis based on a prospective twin study. Gastroenterology 149 (2015), 1784–1793.
13. Kim, C., Harlow, S.D., Karvonen-Gutierrez, C.A., et al. Racial/ethnic differences in hepatic steatosis in a population-based cohort of post-menopausal women: the Michigan Study of Women's Health Across the Nation. Diabet Med 30 (2013), 1433–1441.
14. Solga, S.F., Clark, J.M., Alkhuraishi, A.R., et al. Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients. Surg Obes Relat Dis 1 (2005), 6–11.
15. Stepanova, M., Hossain, N., Afendy, A., et al. Hepatic gene expression of caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease. Obes Surg 20 (2010), 640–650.
16. North, K.E., Graff, M., Franceschini, N., et al. Sex and race differences in the prevalence of fatty liver disease as measured by computed tomography liver attenuation in European American and African American participants of the NHLBI family heart study. Eur J Gastroenterol Hepatol 24 (2012), 9–16.
17. Corey, K.E., Misdraji, J., Zheng, H., et al. The absence of obstructive sleep apnea may protect against non-alcoholic fatty liver in patients undergoing bariatric surgery. PloS One, 8, 2013, e62504.
18. Garcia, A.E., Kasim, N., Tamboli, R.A., et al. Lipoprotein profiles in class III obese caucasian and African American women with nonalcoholic fatty liver disease. PloS One, 10, 2015, e0142676.
19. Browning, J.D., Szczepaniak, L.S., Dobbins, R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 (2004), 1387–1395.
20. Reddy, S.K., Zhan, M., Alexander, H.R., et al. Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders. World J Gastroenterol 19 (2013), 8301–8311.
21. Tison, G.H., Blaha, M.J., Nasir, K., et al. Relation of anthropometric obesity and computed tomography measured nonalcoholic fatty liver disease (from the Multiethnic Study of Atherosclerosis). Am J Cardiol 116 (2015), 541–546.
22. Williams, C.D., Stengel, J., Asike, M.I., et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140 (2011), 124–131.
23. Bril, F., Subbarayan, S., Maximos, M., et al. Prevalence of nonalcoholic fatty liver disease (NAFLD) and disease severity among African Americans (AA) with prediabetes (PREDM) or type 2 diabetes (T2DM). Diabetes, 63, 2014, A465.
24. Chen, J., Mathew, M., Finch, J., et al. The prevalence of NAFLD in T2DM is highest among Hispanics and is closely related to hepatic and adipose tissue insulin resistance. Diabetes, 58, 2009 no pagination.
25. Kallwitz, E.R., Guzman, G., TenCate, V., et al. The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients. Am J Gastroenterol 104 (2009), 64–69.
26. Setiawan, V.W., Porcel, J., Lu, S.C., et al. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups in the United States: the multiethnic cohort (MEC). Gastroenterology, 150, 2016, S1141.
27. Bambha, K., Belt, P., Abraham, M., et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology 55 (2012), 769–780.
28. Campos, G.M., Bambha, K., Vittinghoff, E., et al. A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients. Hepatology 47 (2008), 1916–1923.
29. Corbin, K.D., Abdelmalek, M.F., Spencer, M.D., et al. Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis. FASEB J 27 (2013), 1674–1689.
30. Ha, N.B., Trinh, S., Le, R.H., et al. Disease presentation and natural history of non-alcoholic fatty liver disease (NAFLD) in an ethnically diverse U.S. patient population: a long-term follow-up study. Gastroenterology, 150, 2016, S1055.
31. Hossain, N., Afendy, A., Stepanova, M., et al. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 7 (2009), 1224–1229.
32. Lomonaco, R., Ortiz-Lopez, C., Orsak, B., et al. Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis. Hepatology 54 (2011), 837–845.
33. Mohanty, S.R., Troy, T.N., Huo, D., et al. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. J Hepatol 50 (2009), 797–804.
34. Nelson, J.E., Bhattacharya, R., Lindor, K.D., et al. HFE C282Y mutations are associated with advanced hepatic fibrosis in caucasians with nonalcoholic steatohepatitis. Hepatology 46 (2007), 723–729.
35. Pimentel, C.F.M.G., Jiang, Z.G., Otsubo, T., et al. Poor inter-test reliability between CK18 kits as a biomarker of NASH. Dig Dis Sci 61 (2016), 905–912.
36. Rafiq, N., Bai, C., Fang, Y., et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 7 (2009), 234–238.
37. Tabibian, J.H., Lazo, M., Durazo, F.A., et al. Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?. J Gastroenterol Hepatol 26 (2011), 501–509.
38. Verna, E.C., Patel, J., Bettencourt, R., et al. Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 42 (2015), 582–590.
39. De Martini, S., Wei, E., Wakil, A.E., et al. Racial differences in cirrhosis, hepatocellular carcinoma and liver transplantation among patients with nonalcoholic fatty liver disease. Gastroenterology, 146, 2014 S–946.
40. Stepanova, M., Rafiq, N., Makhlouf, H., et al. Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci 58 (2013), 3017–3023.
41. Ditah, I.C., Ngwa, T.N., Ndzengue, A., et al. Racial disparities in nonalcoholic fatty liver disease related mortality among US Adults: results of the National Health and Nutrition Examination Survey 18-year mortality follow-up data. Hepatology, 60, 2014, 594A.
42. Yip, B., Yee, B.E., Do, A., et al. Characteristics and clinical outcomes of a diverse cohort of patients with biopsy-proven non-alcoholic fatty liver disease (NAFLD). Hepatology, 62, 2015, 1303A.
43. Younossi, Z.M., Otgonsuren, M., Venkatesan, C., et al. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism 62 (2013), 352–360.
44. Menke, A., Casagrande, S., Geiss, L., et al. Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA 314 (2015), 1021–1029.
45. Romeo, S., Kozlitina, J., Xing, C., et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40 (2008), 1461–1465.
46. Kozlitina, J., Smagris, E., Stender, S., et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 46 (2014), 352–356.
47. Mancina, R.M., Dongiovanni, P., Petta, S., et al. The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent. Gastroenterology 150 (2016), 1219–1230.
48. Bhatt, S.P., Nigam, P., Misra, A., et al. Genetic variation in the patatin-like phospholipase domain-containing protein-3 (PNPLA-3) gene in Asian Indians with nonalcoholic fatty liver disease. Metab Syndr Relat Disord 11 (2013), 329–335.
49. Rotman, Y., Koh, C., Zmuda, J.M., et al. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 52 (2010), 894–903.